Table 1. The effect of G-1 treatment on human CASMCs for 48 hours.

	G0/G1		S		G2/M
	Mean	Change after treatment (%)	Mean	Change after treatment (%)	Mean	Change after treatment (%)
Control	82.27		9.82		7.91
G 10−8	84.58	2.81	9.00	−8.35	6.42	−18.84
G 10−6	85.03	3.26	6.64	−32.38	8.33	5.31
G 10−5	91.58	10.95	4.05	−58.76	4.37	−44.75
PDGF	79.77	−2.96	7.78	−20.77	12.45	57.40
G10−6+P	72.27	−12.54	9.78	−0.41	11.90	50.44